世界のトップ30医薬品製造受託機関(CMO)...市場調査レポートについてご紹介

【英文タイトル】Pharma Leader Series: Top 30 Pharmaceutical Contract Manufacturing Organisations (CMOs) – Market, Industry, Trends, Technologies and Prospects 2015-2025

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1. Report Overview
1.1 Leading Contract Manufacturing Organisations (CMOs) Overview
1.2 Benefits of This Report
1.3 How This Report Delivers Information
1.4 Main Questions This Report Answers
1.5 Who is This Report For?
1.6 Methods of Research and Analysis
1.7 Frequently Asked Questions (FAQs)
1.8 Some Related Reports
1.9 About Visiongain

2. Introduction to Pharmaceutical Contract Manufacturing, 2015
2.1 What Services Do Contract Manufacturers Offer?
2.1.1 Why Do Firms Outsource Manufacturing?
2.1.2 What Is Driving Demand for Contract Manufacturing Services?
2.2 The Pharmaceutical Contract Manufacturing Market, 2014
2.2.1 Where is Supply and Demand Highest for Contract Manufacturing Services?
2.3 Outlook for the Pharmaceutical Contract Manufacturing Market 2015-2025
2.4 Driving and Restrictive Forces for Pharmaceutical Contract Manufacturing, 2015-2025
2.4.1 Pharmaceutical Contract Manufacturing: Market Drivers 2015-2025
2.4.2 Pharmaceutical Contract Manufacturing: Market Restraints 2015-2025
2.5 Who Are the Leading Pharmaceutical Contract Manufacturers in 2014?

3. Leading CMOs in North America
3.1 Catalent Pharma Solutions- One of the World’s Leading CMO
3.1.1 Catalent: Manufacturing Services and Capabilities
3.1.2 Divisional Segmentation – Breaking Down Catalent’s Service
3.1.3 Catalent Pharma’s Revenue Growth, 2010-2014
3.1.4 Sustained Growth in Oral Products: Catalent Pharma’s Divisional Performance, 2010-2014
3.1.5 Catalent Is Expanding its Oral Technologies Division
3.1.6 Quadrupling Biopharmaceutical Manufacturing Capacity
3.1.7 Expansion of Packaging Services in Asia-Pacific and Europe: 2015
3.1.8 Adding New Early-Stage Development Services
3.1.9 Expansion in Japan – Growth Prospects for Catalent
3.1.10 New Business Contracts 2014-2015
3.1.11 Catalent New Products Launch
3.1.12 Catalent: Opportunities for Growth 2015-2025
3.1.13 Catalent: Mild Growth in Revenue, 2015-2025
3.2 Patheon – One of The Top 3 CMOs
3.2.1 Patheon – Global leader in Pharmaceutical Development Services
3.2.2 Contract Manufacturing Services at Patheon
3.2.3 Steady Revenue Growth 2010-2014
3.2.4 DPx Holdings: Developments
3.2.5 Adding New Formulations and Formulation Development Services
3.2.6 Reassessing Manufacturing Capacity
3.2.7 Expanding Services Through Acquisition, 2015
3.2.8 Patheon: SWOT Analysis 2015-2025
3.2.9 Patheon: Contract Manufacturing Revenue Forecast 2015-2025
3.3 Baxter BioPharma Solutions
3.3.1 Baxter BioPharma is the Global Leader in Sterile Fill and Finish
3.3.2 Historic Revenue Performance 2010-2014
3.3.3 Baxter BioPharma SWOT Analysis 2015-2025
3.3.4 Baxter BioPharma Revenue Forecast 2015-2025
3.4 AbbVie Contract Manufacturing
3.4.1 AbbVie Offers Full-Service Contract Manufacturing
3.4.2 Expanding and Adding New Services: 2013-2014
3.4.3 AbbVie Contract Manufacturing: Revenue 2011-2014
3.4.4 Biologics and HPAPIs Are an Opportunity for Growth 2015-2025
3.4.5 AbbVie Contract Manufacturing Revenue Forecast 2015-2025
3.5 Pfizer CentreSource
3.5.1 Pfizer CentreSource: Historic Revenue Performance, 2010-2014
3.5.2 Will Pfizer Divest CentreSource?
3.5.3 Outlook for CentreSource: Revenue Forecast 2015-2025

4. Leading European Contract Manufacturing Organisations
4.1 Lonza
4.1.1 Lonza Is a Leader in Biologics Manufacturing
4.1.2 Lonza Contract Manufacturing and Development: 2010-2014
4.1.3 Investing in Advanced Biological Drug Sectors
4.1.4 The Promise of Antibody-Drug Conjugates (ADCs)
4.1.5 The Regenerative Medicine Future in Japan
4.1.6 Lonza: SWOT Analysis 2015-2025
4.1.7 Biologics and Efficiency Savings Will Drive Growth in Revenue and Operating Profit for Lonza 2015-2025
4.2 Evonik Degussa
4.2.1 Investing in API and Drug Delivery Services
4.2.2 Moderate Growth in Pharmaceutical Manufacturing Services, 2010-2014
4.2.3 Evonik Is a HPAPI Specialist
4.2.4 Evonik Continues to Grow Across All Segments
4.2.5 How Can Evonik Expand in the Pharmaceutical Contract Manufacturing Market?
4.2.6 Evonik Degussa: Revenue Forecast 2015-2025
4.3 Royal DSM – The World’s Leading CMO
4.3.1 Amplified Revenue Growth in Pharma Manufacturing 2010-2014
4.3.2 DSM Pharmaceuticals Products: Manufacturing Services 2010-2014
4.3.3 DSM Sinochem Pharmaceuticals: A World Leader in Antibacterial Manufacturing
4.3.4 DPx Holdings: A New Pharma Leader
4.3.5 Investing in Biopharma Manufacturing
4.3.6 Expanding API Manufacturing
4.3.7 Generics and Biologics Are an Opportunity for Growth, 2014-2025
4.3.8 DSM Pharmaceuticals Products: Revenue Forecast 2015-2025
4.4 Boehringer Ingelheim Contract Manufacturing
4.4.1 Expanding Biopharmaceuticals Manufacturing Services in China
4.4.2 Production Through to Fill and Finished Biopharmaceuticals
4.4.3 A Track Record of Production for 29 Biopharma Products
4.4.4 Increasing Revenue from Contract Manufacturing, 2010-2014
4.4.5 Pulling Out of Small Molecule API Manufacturing
4.4.6 Expanding through New Services
4.4.7 Boehringer Ingelheim Biopharmaceuticals: Opportunities for Growth 2015-2025
4.4.8 Boehringer Ingelheim: Revenue Forecast 2015-2025
4.5 Fareva
4.5.1 Fareva Has 35 Years’ Manufacturing Experience
4.5.2 Revenue Growth through Acquisitions: 2010-2014
4.5.3 Fareva SWOT Analysis: 2015
4.5.4 Fareva Revenue Forecast: 2015-2025
4.6 Aenova Group
4.6.1 Acquisition of Haupt Creates European CMO Giant
4.6.2 Aenova’s Ever Expanding Manufacturing Capacity
4.6.3 Aenova’s Revenue 2010-2014: Organic Growth and Acquisitions
4.6.4 Aenova’s Competitive Position in the Contract Manufacturing Market: SWOT Analysis 2015
4.6.5 Becoming a Leading Contract Manufacturer: Aenova Revenue Forecast 2015-2025
4.7 Famar
4.7.1 Famar Is an Expert in Lyophilisation
4.7.2 Sustained Growth in Famar’s Revenue: 2010-2014
4.7.3 Expanding European Operations
4.7.4 Further Site Acquisitions Are an Opportunity for Growth 2015-2025
4.7.5 How Will Famar Perform 2015-2025?
4.8 Vetter Pharmaceutical
4.8.1 Vetter is an Injectable Manufacturing Specialist
4.8.2 Rapidly Growing Revenue in the US and Germany: 2010-2014
4.8.3 Services, Collaborations and Differentiating Factors
4.8.4 Expanding Services in US and Asia
4.8.5 Biologics Are an Opportunity for Growth for Vetter 2015-2025
4.8.6 Vetter Outlook: Revenue Forecast 2015-2025
4.9 Almac Group
4.9.1 Almac’s Manufacturing Services
4.9.2 Almac Outpaces the Market: 2011-2014
4.9.3 Almac Adding Capacity Globally
4.9.4 New Services Added 2012-2015
4.9.5 Almac Group: Contract Manufacturing Market Outlook 2015-2025
4.9.6 How Will Almac Group Perform 2015-2025?
4.10 Delpharm
4.10.1 Finished Dosage Form Manufacturing for Developed Markets
4.10.2 Delpharm: Rapid Revenue Growth Via Acquisitions, 2010-2014
4.10.3 Delpharm: Outlook and Prospects for Growth 2015-2025
4.10.4 Generics Will Drive Revenue Growth for Delpharm 2015-2025
4.11 Siegfried
4.11.1 Siegfried’s Acquisitions, 2010-2014
4.11.2 Expanding Siegfried’s Manufacturing Footprint Globally
4.11.3 Expanding High Potency API Capabilities
4.11.4 Siegfried: Financial Performance 2010-2014
4.11.5 Siegfried’s Characteristics within the Contract Manufacturing Market: SWOT Analysis 2015
4.11.6 Continued Revenue Growth for Siegfried 2015-2025
4.12 Corden Pharmaceutical
4.12.1 CordenPharma Service Division
4.12.2 CordenPharma Emerging in the API Market
4.12.3 Investments in Highly Potent Capabilities
4.12.4 CordenPharma: SWOT Analysis 2015-2025
4.13 Recipharm
4.13.1 Contract Development and Manufacturing Services
4.13.2 Recipharm: Financial Performance 2010-2014
4.13.3 Recipharm Invests in Facility Expansion
4.13.4 Recipharm Growing in Development & Technology Market through Acquisitions
4.13.5 Recipharm: Opportunities for Growth 2015-2025
4.13.6 Outlook for Recipharm: Revenue Forecast 2015-2025
4.14 Aesica Pharmaceuticals
4.14.1 Aesica Manufactures APIs and Finished Dosage Forms
4.14.2 Acquisitions Drive Revenue Growth but Operational Margins Have Declined, 2010-2014
4.14.3 Partnering with Academia for Innovative Solutions
4.14.4 Growth through Acquisitions and Internal Expansion
4.14.5 Aesica: Opportunities for Expansion 2015-2025
4.14.6 Forecast Aesica Financial Performance, 2015-2025

5. Leading Japanese Pharma Contract Manufacturing Organisations
5.1 Nipro Corporation: Japan’s Leading CMO
5.1.1 Nipro Pharmaceutical Contract Manufacturing Capabilities
5.1.2 Nipro: Decline in Revenue But Increasing Operating Profits 2010-2014
5.1.3 Biosimilars and Anti-Cancer Drugs Are Opportunities for Future Growth: SWOT Analysis 2015
5.1.4 Nipro Revenue and Profitability Forecast 2015-2025
5.2 Daito Pharmaceutical
5.2.1 Daito Has a Portfolio of More than 30 APIs
5.2.2 Rapid Growth in Revenue and Operational Profit: Daito Financial Performance 2010-2014
5.2.3 Daito Is Well-Placed for Asian Market Growth – SWOT Analysis 2015-2025
5.2.4 Sustained Growth in Revenue and Operating Profit for Daito, 2015-2025

6. Leading Developed-Market API Specialists
6.1 Teva API
6.1.1 API Manufacturing Services
6.1.2 Teva API: Financial Performance 2010-2014
6.1.3 Building a Footprint in Mexico, India and China
6.1.4 Teva API: SWOT Analysis 2015
6.1.5 Outlook for Teva API: Revenue Forecast 2015-2025
6.2 Esteve Química
6.2.1 Esteve Química Manufactures APIs for Developed and Emerging Markets
6.2.2 Expanding in The US, 2015
6.2.3 Esteve Química: SWOT Analysis 2015-2025
6.3 Euticals
6.3.1 Euticals Manufactures More than 200 APIs
6.3.2 Acquisitions Drive Growth 2010-2014
6.3.3 Adding Capacity for Finished Dosage Forms
6.3.4 Asian Expansion Is an Opportunity for Growth 2015-2025
6.3.5 Euticals: Revenue Forecast 2015-2025

7. Leading Chinese Pharmaceutical Contract Manufacturers
7.1 Zhejiang Hisun Pharmaceutical
7.1.1 API Manufacturing for Markets Worldwide
7.1.2 Zhejiang Hisun’s Rapid Growth in API Revenue Grows, 2010-2014
7.1.3 Moving Into International Drug Marketing
7.1.4 Zhejiang Hisun: Opportunities for Growth 2015-2025
7.1.5 Zhejiang Hisun: Strong API Revenue Growth 2015-2025
7.2 Zhejiang Huahai Pharmaceuticals
7.2.1 Zhejiang Huahai Is a Market Leader Within The Antihypertensive API Market
7.2.2 Zhejiang Huahai: Contract Manufacturing Performance 2010-2014
7.2.3 Expanding in the US Generic Drugs Market
7.2.4 Zhejiang Huahai: SWOT Analysis, 2015
7.2.5 Zhejiang Huahai: Revenue Forecast, 2015-2025
7.3 Shandong Xinhua Pharmaceutical
7.3.1 Experience in APIs and Finished Dosage Forms
7.3.2 Shandong Xinhua: Strong Revenue Growth 2010-2014
7.3.3 Growing through Joint Ventures
7.3.4 Looking to Expand in the US and EU 2015-2025
7.3.5 Shandong Xinhua Pharmaceutical: Revenue Forecast 2015-2025

8. Leading Indian Pharmaceutical Contract Manufacturers
8.1 Aurobindo Pharma
8.1.1 API Manufacturing Services
8.1.2 Aurobindo Pharma: Steady Revenue Growth 2010-2014
8.1.3 Aurobindo Expanding Outside of Antibacterials
8.1.4 Aurobindo: Opportunities for Expansion 2015-2025
8.1.5 How Will Aurobindo’s Contract Manufacturing Division Perform 2015-2025?
8.2 Divis Laboratories
8.2.1 Divis Laboratories and the Contract Manufacturing Industry
8.2.2 Divis Laboratories: A Rapidly Growing CMO, 2010-2014
8.2.3 Divis Laboratories: API Manufacturing Outlook 2015-2025
8.2.4 Divis Laboratories: API Manufacturing Revenue Forecast, 2015-2025
8.3 Dr. Reddy’s Laboratories
8.3.1 API and FDF Manufacturing Services
8.3.2 Dr. Reddy’s PSAI: Strong Revenue Growth 2010-2014
8.3.3 Advancing in Complex Drug Manufacturing
8.3.4 Expanding in the European Manufacturing Market
8.3.5 Dr. Reddy’s PSAI Division: Revenue Forecast 2015-2025

9. Research Interviews from Our Industry Survey
9.1 Dr Michael Quirmbach, Vice President, Global Sales & Marketing, CPI, Corden Pharma
9.2 Mrs Marianne Spaene, Executive Vice President, Global Head Business Development, Sales and Marketing, Siegfried
9.3 Dr Prabuddha Kundu, Cofounder & Executive Director, PREMAS Biotech

10. Conclusions of the Study
10.1 What Has Driven Growth for CMO Market Leaders in Recent Years?
10.2 Strategies for Growth: Prospects For Leading CMOs, 2015-2025
10.3 High Demand for Biopharmaceutical Manufacturing Services
10.4 Investing in Novel Technologies
10.5 Outlook for API Manufacturers


【レポート販売概要】

■ タイトル:世界のトップ30医薬品製造受託機関(CMO)
■ 英文:Pharma Leader Series: Top 30 Pharmaceutical Contract Manufacturing Organisations (CMOs) – Market, Industry, Trends, Technologies and Prospects 2015-2025
■ 発行日:2015年9月
■ 調査会社:visiongain
■ 商品コード:VGAIN5100108
■ 調査対象地域:グローバル
  • 石油及びガス産業における上流工程分野のM&A動向:Q1 2014
    Upstream Oil and Gas Quarterly Deals Review, Q1 2014 Summary GlobalData's “Upstream Oil and Gas Quarterly Deals Review, Q1 2014” report is an essential source of data and trend analysis on mergers and acquisitions (M&As) and financings in the upstream oil and gas industry. The report provides detailed information on M&As, equity/debt offerings, partnerships, and PE/VC transactions registered in th …
  • 噴霧乾燥装置の世界市場予測(~2022):種類別(回転噴霧器、ノズル噴霧器、流動層、閉ループ、遠心)、用途別、乾燥ステージ別、サイクル種類別、フロー種類別、地域別
    The spray drying equipment is projected to grow at a CAGR of 7.03% from 2016 to 2022, to reach a projected value of USD 5.80 Billion by 2022. In the spray drying equipment market, nozzle and rotary atomizer spray dryers are largely preferred in the food processing industry, followed by the centrifugal and fluidized spray dryers. The market for spray drying is largely dependent on the demand for pr …
  • 補助人工心臓の世界市場:左室補助人工心臓(LVAD)、右室補助人工心臓(RVAD)、両心補助人工心臓(BiVAD)
    About Ventricular Assist Devices Heart failure is a medical condition wherein the heart loses its ability to pump enough blood to circulate throughout the body. In such a condition, a patient can survive by having heart transplantation with a healthy heart. A VAD is a medical device that is used to support the patient with either acute or chronic cardiac functional deterioration. It is a mechanica …
  • 世界の創傷閉鎖ストリップ市場:製品別、地域別
    Global Wound Closure Strips Market: About this market Technavio’s wound closure strips market analysis considers sales from elastic wound closure strips, reinforced wound closure strips, and other wound closure strips. Our study also finds the sales of wound closure strips in Asia, Europe, North America, and ROW. In 2019, the elastic wound closure strips segment had a significant market share, and …
  • 平ガラスの世界市場分析:製品別(強化、ラミネート、基本フロート、断熱)、用途別(自動車、建設)、セグメント予測
    Global Flat Glass market is expected to reach USD 124.14 billion by 2022, according to a new study by Grand View Research, Inc. Rising awareness regarding benefits of glass usage in building & construction including safety, security and energy savings is expected to drive flat glass market over the forecast period. Product innovations in terms of improved characteristics coupled with introduction …
  • 吹付けコンクリートの世界市場動向及び予測
    Shotcrete/sprayed concrete is a specialty concrete material applied by spraying through a sealed, pressure-resistant hose or pipe. Shotcrete is a cost-effective method for applying concrete as formwork is not required. Shotcrete exhibits certain properties, such as high strength, low permeability, and high durability that make it superior to poured concrete. It can be used in a wide variety of con …
  • 世界のコンタクトレンズ市場動向(2012-2016)
    TechNavio's analysts forecast the Global Contact Lens market to grow at a CAGR of 8.6 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing prevalence of eye disorders. The Global Contact Lens market has also been witnessing the increasing adoption of a product bundling strategy. However, increasing product recalls could pose a challenge to …
  • Saudi ArabiaのCalcium Chloride市場:貿易(輸入、輸出)動向
    This market research report examines the foreign trade of Saudi Arabia and its perspectives on the global market for calcium chloride. The report will be of considerable interest primarily to relevant strategic planners, senior company officials and importers/exporters, since it features invaluable information on calcium chloride export/import operations in Saudi Arabia. The 2002-2012 period is co …
  • ガス化技術の世界市場2015-2019
    About Gasification Gasification is a thermochemical process that converts hydrocarbons such as coal, petroleum, petcoke, natural gas, and biomass into simple molecules, primarily resulting in a mixture called syngas (carbon monoxide and hydrogen) by means of partial oxidation with air, oxygen, or steam. The key advantage of gasification is its ability to perform in various designs having a reduced …
  • 細菌性バイオ農薬の世界市場:バチルス・チューリンゲンシス、枯草菌、蛍光菌
    This report covers the Global Bacterial Biopesticides Market. It segments the market on the basis of geography, applications, type of bacteria, and crop type. The market data for these segments is given with respect to value (USD Million) and volume (KT). The market value of the bacterial biopesticides market was estimated to be $1438.6 million in 2014 and is projected to grow with a CAGR 13.4% fr …
  • タンタルの世界市場2015-2019
    About Tantalum Tantalum is a heavy, hard, and grey metallic element. It is resistant to chemical attacks at temperatures below 150°C. Tantalum is a rare earth metal and is not found in large amounts. Tantalum exhibits resistance to corrosion due to presence of an oxide film on its surface. Melting point of tantalum is quite high and is lower only to tungsten and rhenium. The metal exhibits maximum …
  • コートジボワールの生命保険市場
    "Trends and Opportunities in Cote d’Ivoire Life Insurance Industry to 2018: Market Profile" is the result of extensive research into the life insurance segment in Cote d’Ivoire. It provides insights into the market trends, market size, growth prospects and market efficiency in the Ivoirian life insurance market.
  • ジオテキスタイルの世界市場2016-2026
    Geotextiles are part of the geosynthetic group of materials which include geogrids, geomembranes, geopipes, geocomposites, geosynthetic clay liners, and geonets. A wide range of sectors have used geotextiles since 1950. The first geotextiles were woven industrial fabrics. Initially, they were used for waterfront structures, then the first nonwoven geotextiles for construction purposes were develop …
  • Sui Northern Gas Pipelines Limited:石油・ガスバリューチェーン分析レポート2013
    Sui Northern Gas Pipelines Limited Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Sui Northern Gas Pipelines Limited" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Sui Northern Gas Pipelines Limited”. The report provides key information relating to oil and gas assets of the company along with its operatio …
  • 医療放射線遮蔽の世界市場:X線撮影室、シールド、ブース、シート、鉛、レンガ、カーテン
    The global medical radiation shielding market is expected to reach USD 1330.0 Million by 2021 from USD 989.2 Million in 2016, at a CAGR of 6.1%. This market is segmented based on product, solution, and end user. The global medical radiation shielding market includes product, solutions, and end user. A number of factors, such as the growing incidences of cancer, increasing usage of nuclear medicine …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。